Search

everythinglearnresearchcommunity

for

Search:↓

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Using blood-based implants improves skin healing and reduces scarring.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Testosterone reduces, while finasteride enhances, morphine's pain relief.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Activated ras can protect kidney cells from a certain substance that causes cell death.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Optimized liposomes can improve drug delivery and effectiveness.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.